System pharmacology-based study on mechanism of Polygala Radix in the treatment of Alzheimer's disease
10.16438/j.0513-4870.2017-0541
- VernacularTitle:基于系统药理学研究远志治疗阿尔茨海默病的作用机制
- Author:
Hao WANG
1
;
Zhen-yu ZHAO
1
;
Xia SHEN
1
;
Ben-xiang HU
1
;
Ying CHEN
1
Author Information
1. School of Pharmaceutical Science, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, China
- Publication Type:ORIGINAL ARTICLES
- Keywords:
Polygala Radix;
system pharmacology;
Alzheimer's disease;
mechanism;
virtual screening
- From:
Acta Pharmaceutica Sinica
2017;52(10):1554-1560
- CountryChina
- Language:Chinese
-
Abstract:
This study was designed to investigate the molecular mechanism and potential active constituents of Polygala Radix in the treatment of Alzheimer's disease with multiple data bases combined with literature mining to build Polygala Radix chemical composition database. A novel analysis tool Pharmmapper was used to obtain the main active ingredient and potential target of Polygala Radix. By extensive data profiling, the Polygala Radix was found to contain 111 chemical constituents. Among them, a total of 10 active molecules included 3 xanthone, 1 saponins, 3 oligosaccharide esters, and 3 other classes were related to 13 Alzheimer's disease-related targets. Two of the core targets were beta-secretase 1 and glycogen synthase kinase-3 beta. Use the GO analysis and KEGG to explore the molecular mechanism of Polygala Radix in treatment of Alzheimer's disease, which has 3 signaling pathways, and the most important signaling pathway is the cell death signaling pathway. The active constituents of Polygala Radix could control the formation of Aβ and the apoptosis of cells through the interaction with multiple targets, and control the treatment of Alzheimer's disease.
